These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 2900134

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Prevention of tardive dyskinesia caused by neuroleptic therapy].
    Perényi A.
    Orv Hetil; 1981 Jul 05; 122(27):1627-30. PubMed ID: 6117046
    [No Abstract] [Full Text] [Related]

  • 23. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
    Casey DE, Povlsen UJ, Meidahl B, Gerlach J.
    Psychopharmacol Bull; 1986 Jul 05; 22(1):250-3. PubMed ID: 2873612
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Tardive dyskinesia and informed consent: myths and realities.
    Munetz MR, Roth LH, Cornes CL.
    Bull Am Acad Psychiatry Law; 1982 Jul 05; 10(2):77-88. PubMed ID: 6129012
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM.
    J Clin Psychiatry; 2004 Jul 05; 65 Suppl 9():16-20. PubMed ID: 15189107
    [Abstract] [Full Text] [Related]

  • 29. Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series.
    Bona JR.
    J Clin Psychopharmacol; 2006 Apr 05; 26(2):215-6. PubMed ID: 16633158
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Does clozapine cause tardive dyskinesia?
    Kane JM, Woerner MG, Pollack S, Safferman AZ, Lieberman JA.
    J Clin Psychiatry; 1993 Sep 05; 54(9):327-30. PubMed ID: 8104929
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):761-4. PubMed ID: 18201810
    [Abstract] [Full Text] [Related]

  • 34. [Current data on neurologic sequelae caused by neuroleptics].
    Krebs MO.
    Encephale; 1995 Jun 01; 21 Spec No 3():49-52. PubMed ID: 7628342
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Tardive dyskinesia: problems of pathogenesis, treatment and prevention].
    Olajossy M.
    Psychiatr Pol; 1980 Jun 01; 14(6):621-5. PubMed ID: 6112766
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Neuroleptic-induced tardive dyskinesias in France].
    Bourgeois M.
    Encephale; 1988 Sep 01; 14 Spec No():195-201. PubMed ID: 2905646
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.